Keep up to date with every new upload!

Join free & follow Cancer Network Podcasts
Share
  • 6 years ago
Novel Agents in Early Trials for Breast Cancer

Novel Agents in Early Trials for Breast Cancer

We speak with Dr. Sara Hurvitz, director of the breast cancer program at the University of California in Los Angeles. Dr. Hurvitz is actively involved in translational phase I/II breast cancer clinical trials as well as in research to better define distinct types of breast tumors to better design novel targeted therapies.

Comments